Business Context and Reporting Period
Company: Herbalife Ltd.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2007
Business Overview: Herbalife is a global network marketing company selling weight management, nutritional supplements, energy & fitness, and personal care products. It operates in 65 countries through a network of over 1.7 million independent distributors, except in China where it utilizes retail stores and an employed sales force due to local regulations.
Key Financial Metrics (Year Ended Dec 31, 2007)
| Metric | 2007 Value | 2006 Value |
|---|---|---|
| Net Sales | $2,145.8 million | $1,885.5 million |
| Net Income | $191.5 million | $143.1 million |
| Diluted EPS | $2.63 | $1.92 |
| Operating Income | $313.2 million | $256.9 million |
| Operating Margin | 14.6% | 13.6% |
| Gross Margin | 79.6% | 79.8% |
| Operating Cash Flow | $270.8 million | $184.4 million |
| Total Debt | $365.2 million | $185.4 million |
| Cash and Equivalents | $187.4 million | $154.3 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 13.8% year-over-year, driven by growth in the U.S. (23.9%), China (136.9%), Venezuela (317.3%), and Taiwan (27.7%). Foreign currency appreciation contributed a $73.0 million favorable impact.
- Profitability: Net income rose 33.8%, aided by revenue growth, expanded operating margins, and a significant reduction in interest expense following a 2006 debt refinancing.
- Debt Structure: Total debt increased to $365.2 million from $185.4 million. This increase was primarily due to borrowings under the revolving credit facility used to fund a $365.8 million share repurchase program.
- Shareholder Returns: The company initiated a quarterly cash dividend program in 2007, paying $41.5 million in aggregate dividends. Additionally, the company repurchased approximately 9.1 million shares during the year.
- Product Mix: Weight Management products remained the largest category at 63.4% of net sales. Outer Nutrition sales declined 4.9% due to product mix changes and distributor shifts toward other categories.
Guidance, Outlook, Risks, and Contingencies
Outlook and Strategy
- China Expansion: Management views China as a significant growth opportunity. The company received a direct-selling license for Jiangsu province in July 2007 and operates 90 retail stores across 29 provinces. Expansion into additional provinces is ongoing.
- Realignment for Growth: The company is in the second phase of a restructuring plan. Management expects to incur an additional $4.0 million to $6.0 million in severance and related costs in 2008.
- Capital Expenditures: Expected to be approximately $95.1 million in 2008, focusing on IT infrastructure and facility expansion.
Risks and Contingencies
- Regulatory Scrutiny: The company faces ongoing regulatory risks regarding its network marketing model, product claims, and ingredients (e.g., FDA cGMP compliance, EU health claim regulations). It is subject to audits in various jurisdictions regarding transfer pricing and income taxes.
- Legal Proceedings:
- Minton v. Herbalife: A class action lawsuit regarding "endless chain schemes" was granted California-only class certification in January 2007. The company believes it has meritorious defenses.
- Mey v. Herbalife: A TCPA class action lawsuit was settled for $7 million (fully reserved) with final court approval in January 2008.
- SEC Inquiry: The SEC issued a formal order of investigation regarding trading by a former mid-level employee and requested documents regarding distributor product usage. The company is cooperating.
- Product Liability: The company maintains product liability insurance with a $10 million annual deductible. It faces potential claims related to historical products containing ephedrine alkaloids.
- Foreign Exchange: Approximately 80% of sales are generated outside the U.S., exposing the company to currency fluctuation risks. A strengthening U.S. dollar could negatively impact reported sales and margins.
Key Facts for Investor Verification
- Distributor Retention: Verify the sustainability of the 42.5% supervisor retention rate (excluding China) and the impact of high turnover on future sales growth.
- China Operations: Monitor the progress of obtaining additional direct-selling licenses in China and the associated regulatory compliance costs, as this market represents a major growth driver but also a significant risk.
- Debt Covenants: Review the terms of the $300 million senior secured credit facility, specifically the covenants restricting dividends and share repurchases, which are tied to net income levels.
- Tax Reserves: Assess the $50.3 million in unrecognized tax benefits and the potential impact of ongoing international tax audits on future earnings.
- Share Repurchases: Confirm the remaining capacity under the $450 million share repurchase authorization and the company's commitment to returning capital to shareholders via dividends and buybacks.